Search

Filters

Clear Filters
2:50 PM - 3:00 PM PT

136 - E2F1-Fanconi Anemia Complementation Group I (FANCI) Mediates Oncogenic BRAF-Driven Radiation Resistance in Anaplastic Thyroid Cancer
Speaker: Yang, Linlin, MD, PhD - City of Hope Comprehensive Cancer Center, Duarte, CA
3:00 PM - 3:10 PM PT

137 - Exploiting Dependencies Created By KEAP1/NFE2L2 Mutations in NSCLC to Overcome Radiation Resistance
Speaker: Mai, Wilson, MD, PhD - Stanford University Cancer Center, Stanford, CA
3:10 PM - 3:20 PM PT

138 - Radiation-Enhanced CD24 Membrane Trafficking via GPI Anchoring Underlies Immune Evasion after Radiotherapy
Speaker: Kong, Lingyi, MD - Union Hospital Cancer Center, Tongji Medical College, HUST, Wuhan, Hubei
3:20 PM - 3:30 PM PT

139 - Genomic and Transcriptomic Profiling of Radiation Resistant, Locally Recurrent Prostate Cancer
Speaker: Neilsen, Beth, MD, PhD - Stanford Cancer Center South Bay, San Jose, CA
4:45 PM - 4:55 PM PT

140 - Accelerated Partial Breast Irradiation (APBI) Delivered in Three Fractions is Safe and Efficacious: Preliminary Results from a Phase 2 Study
Speaker: Khan, Atif, MD, MS - Memorial Sloan Kettering Cancer Center, New York, NY
4:55 PM - 5:05 PM PT

141 - Preliminary Results of Hypofractionated Regional Nodal Radiation in Breast Cancer (HARVEST): A Randomized Non-Inferior Multi-Center Phase III Trial
Speaker: Xu, Fei-Fei, MD - Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai
5:05 PM - 5:15 PM PT

142 - Moderate Hypofractionated Radiotherapy for Regional Nodal Irradiation and Postmastectomy Radiation Therapy: A Systematic Review and Meta-Analysis
Speaker: Hoerner-Rieber, Juliane, MD - University Hospital Duesseldorf, Department of Radiation Oncology, Düsseldorf, Nordrhein-
5:15 PM - 5:25 PM PT

143 - Accelerated Partial Breast Irradiation to 40 Gy in 10 Daily Fractions: Long-Term Results of a Phase II Study
Speaker: Lapen, Kaitlyn, MD - Memorial Sloan Kettering Cancer Center, New York, NY
5:25 PM - 5:35 PM PT

144 - Early Outcomes of a Phase III Randomized Controlled Trial Comparing Ultra-Hypo Fractionated 5 Fraction Treatment vs. Hypofractionated 15 Fraction Treatment for Patients Receiving Regional Nodal Irradiation
Speaker: Vargas, Carlos, MD - Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ
5:35 PM - 5:45 PM PT

145 - Ultra-Hypofractionated Partial Breast Re-Irradiation for Ipsilateral Breast Cancer Recurrence
Speaker: Nassif, Tracy, MD - Corewell Health William Beaumont University Hospital, Royal Oak, MI
4:45 PM - 4:55 PM PT

146 - Early Detection of Metastatic Progression by Circulating Tumor DNA in Patients Undergoing Bladder-Preserving Trimodality Therapy
Speaker: Zhao, Dekuang, DO, PhD - Moffitt Cancer Center, Tampa, FL
4:55 PM - 5:05 PM PT

147 - Bladder-Specific 15-Gene Transcriptomic Signature Predicts (Chemo)radiation Therapy Response in Muscle-Invasive Bladder Cancer
Speaker: Li, Xiaohui, MD - Peking University First Hospital, Beijing, Beijing